Improved data, methods and tools for the 2007 HIV and AIDS estimates and projections

Sexually Transmitted Infections

Volumn 84, Issue SUPPL. 1, 2008, Pages

  Ghys, Peter D ^a   Walker, N ^b   McFarland, W ^c   Miller, R ^d   Garnett, G P ^e  

^a UNAIDS   (Switzerland)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EPIDEMIOLOGICAL DATA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; MORTALITY; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; DATA COLLECTION; FEMALE; FORECASTING; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED;

EID: 49149124940     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2008.032573     Document Type: Article

References (38)

1. UNAIDS/WHO. AIDS epidemic update: December 2007. UNAIDS/07.27E, JC1 322E. Geneva: UNAIDS, 2007.
2. UNAIDS/WHO. AIDS epidemic update: December 2006. UNAIDS/06.29E. Geneva: UNAIDS, 2006.
3. Walker N, Bryce J, Black RE. Interpreting health statistics for policymaking: the story behind the headlines. Lancet 2007;369:956- 63.
4. Chin J. The AIDS pandemic: the collision of epidemiology and political correctness. Oxford: Radcliffe Publishing, 2007.
5. Ward H, Walker N, Ghys PD, eds. Methods and tools for HIV/AIDS estimates and projections. Sex Transm Infect 2004;80(suppl 1).
6. Ghys P, Walker N, Ward H, et al, eds. Improved methods and tools for HIV/AIDS estimates and projections. Sex Transm Infect 2006;82(suppl 3).
7. UNAIDS. Methods and assumptions for estimates, www.unaids.org.
8. WHO/UNAIDS/UNICEF Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization, June 2008.
9. UNAIDS. 2008 Report on the global AIDS epidemic. Geneva: UNAIDS, 2008.
10. UNAIDS Reference Group on Estimates, Modelling and Projections, www.epidem.org.
11. Gouws E, Mishra V, Fowler TB. Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data. Sex Transm Infect 2008;84(suppl 1):i17-i23.
12. Alkema L, Raftery AE, Brown T. Bayesian melding for estimating uncertainty in national HIV prevalence estimates. Sex Transm Infect 2008;84(suppl 1):i11-i17.
13. Brown T, Salomon JA, Alkema L, et al. Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007. Sex Transm Infect 2008;84(suppl 1):i5-i10.
14. Stover J, Johnson P, Zaba B, et al. The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect 2008;84(suppl 1):i24-i30
15. Todd J, Glynn JR, Marston M, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007;21(suppl 6):S55-63.
16. Marston M, Todd J, Glynn JR, et al. Estimating 'net' HIV-related mortality and the importance of background mortality rates. AIDS 2007;21(suppl 6):S65-71.
17. National Institute of Medical Sciences (Indian Council of Medical Research) and National AIDS Control Organization (Ministry of Health and Family Welfare). Technical report. India HIV estimates-2006. New Delhi: NIMS and NACO, 2007.
18. The eligibility for ART in lower income countries (eART-linc) collaboration. Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex Transm Infect 2008;84(suppl 1):i31-6.
19. WHO/UNAIDS/UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization, April 2007.
20. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach. 2006 revision. Geneva: WHO, 2006.
21. Van der Paal L, Shafer LA, Todd J, et al. HIV-1 disease progression and mortality before the introduction of highly active antiretroviral therapy in rural Uganda. AIDS 2007;21 (suppl 6):S21-9.
22. McGrath N, Kranzer K, Saul J, et al. Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS 2007;21(suppl 6):S105-13.
23. Auvert B, Males S, Puren A, et al. Can highly active antiretroviral therapy reduce the spread of HIV? A study in a township of South Africa. J Acquir Immune Defic Syndr 2004;36:613-21.
24. Boerma JT, Stanecki KA, Newell M-L, et al. Monitoring progress towards 3 by 5. Methods and mid 2005 update. Bull World Health Organ 2006;84:145-50.
25. Kruglov YV, Kobyshcha W, Salyuk T, et al. The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007. Sex Transm Infect 2008;84(suppl 1):i37-i41.
26. Lowicki-Zucca M, Spiegel PB, Kelly S, et al. Estimates of HIV burden in emergencies. Sex Transm Infect 2008;84(suppl 1):i42-8.
27. Cáceres CF, Konda KA, Segura E, et al. Epidemiology of male same-sex behaviour and associated sexual health indicators in low and middle-income countries: 2003-2007 estimates. Sex Transm Infect 2008;84(suppl 1):i49-i56.
28. Robertson L, Gregson S, Madanhire C, et al. Discrepancies between UN models and DHS survey estimates of maternal orphan prevalence: insights from analyses of survey data from Zimbabwe. Sex Transm Infect 2008;84(suppl 1):i57-i62.
29. Mishra V, Barrere B, Hong R, et al. Evaluation of bias in HIV seroprevalence estimates from national household surveys. Sex Transm Infect 2008;84(suppl 1):i63-i70.
30. Marston M, Harriss K, Slaymaker E. Non-response bias in estimates of HIV prevalence due to the mobility of absentees in national population-based surveys: a study of nine national surveys. Sex Transm Infect 2008;84(suppl 1):i71-7.
31. Mishra V, Vaessen M, Boerma JT, et al. HIV testing in national population-based surveys: experience from the Demographic and Health Surveys. Bull World Health Organ 2006;84:537-45.
32. Montana LS, Mishra V, Hong R. Comparison of HIV prevalence estimates from antenatal care surveillance and population-based surveys in sub-Saharan Africa. Sex Transm Infect 2008;84(suppl 1):i78-i84.
33. Lyerla R, Gouws E, Calleja T. The quality of sero-surveillance in low and middle-income countries: status and trends through 2007. Sex Transm Infect 2008;84(suppl 1):i85-i91.
34. Garcia-Calleja JM, Zaniewski E, Ghys PD, et al. A global analysis of trends in the quality of HIV sero-surveillance. Sex Transm Infect 2004;80(suppl 1):i25-i30.
35. Heaton L, Komatsu R, Low-Beer D, et al. Estimating the number of HIV infections averted: an approach and its issues. Sex Transm Infect 2008;84(suppl 1):i92-6.
36. Hallett TB, Zaba B, Todd J, et al. Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med 2008;5:e80. doi:10.1371/joumal.pmed.0050080.
37. McDougal JS, Parekh BS, Peterson ML, et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retrovir 2006;22:945-52.
38. Hargrove JW, Humphrey JH, Mutasa K, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008;22:511-8.